SciELO - Scientific Electronic Library Online

 
vol.31 issue12Incidence of type 1 diabetes mellitus in Passo Fundo, RS, BrazilMonoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Brazilian Journal of Medical and Biological Research

On-line version ISSN 1414-431X

Abstract

SCHWARTZMANN-SOLON, A.M.; VISCONTI, M.A.  and  CASTRUCCI, A.M.L.. Topical application of a melanotropin analogue to vulgar vitiligo dermo-epidermal minigrafts. Braz J Med Biol Res [online]. 1998, vol.31, n.12, pp. 1557-1564. ISSN 1414-431X.  http://dx.doi.org/10.1590/S0100-879X1998001200008.

Human subjects with active vulgar vitiligo do not respond well to autologous dermo-epidermal minigrafting. Eighteen subjects were treated with the a-melanocyte-stimulating hormone (a-MSH) synthetic analogue [Nle4, D-Phe7]-a-MSH. The hormone (50 µl, 0.4 mM) was applied topically to 30-cm2 lesions in which 29-48 minigrafts had been made. The hormone did not improve the success of the minigrafting and no differences were observed in local or distant repigmentation in treated subjects as compared to the placebo group. Aliquots of 24-h urine concentrated by lyophilization irreversibly darkened toad skins, demonstrating the presence of the analogue. This is the first report of the transdermal delivery of a topically applied melanotropin in living human subjects.

Keywords : vulgar vitiligo; a-MSH synthetic analogue; minigrafting.

        · text in English     · pdf in English